Systematic ReviewResearchMedication SafetyPatient Education

Vascular dementia drugs showed small cognitive effects but uncertain patient-important benefit

European journal of clinical pharmacology (PubMed)Aug 24, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A systematic review found small short-term cognitive-score improvements with galantamine and memantine in vascular dementia, but consistent functional, global, and other patient-important benefits were not established.

What NurseJet pulled from the source

Sixteen randomized trials included 5,668 participants across trial cohorts. Galantamine and memantine produced small improvements on selected cognitive scales with moderate-certainty evidence, while EGb 761 had a very low-certainty signal and evidence for other interventions was mainly single-trial and non-poolable. All but one trial was published in 2012 or earlier.

Why this matters for nurses

Geriatric and neuro nurses monitor cognition, function, adverse effects, and caregiver concerns during dementia treatment. The review supports setting cautious expectations: a small change on a cognitive scale may not translate into noticeable functional benefit.

Bedside takeaway

Frame cognitive-score changes cautiously and track whether prescribed therapy produces meaningful functional benefit for the individual patient.

How This Applies in Practice

Use this when: Monitoring an older adult with vascular dementia who is starting or continuing a cognition-targeted medication.

On your shift

Record baseline cognition, function, behavior, and caregiver-reported priorities using the approved assessment approach.
Monitor adherence and medication-specific adverse effects and report changes through the prescribing team's pathway.
Compare follow-up cognition and daily function with the agreed treatment goals and share patient and caregiver observations.

Keep in mind: The review does not support starting or stopping a specific medication without individualized evaluation. Follow the medication plan, facility policy, and provider orders.

Key takeaways

The review included 16 randomized trials and 5,668 participants across trial cohorts.
Galantamine and memantine showed small short-term improvements on selected cognitive scales.
Functional, global, and other patient-important outcomes did not show consistent benefit.
Most evidence was old, and support for several other medications came from single trials or very low-certainty findings.

Practice implications

Document baseline cognition and daily function, verify the indication and monitoring plan for prescribed therapy, watch for medication-specific adverse effects, and include patient and caregiver observations when evaluating whether treatment goals are being met.

Limitations & cautions

Trials used different drugs and outcome scales, most were published in 2012 or earlier, and evidence for many interventions was sparse or non-poolable. Cognitive-score changes were short term and did not establish consistent functional or global benefit.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

European journal of clinical pharmacology (PubMed)

European journal of clinical pharmacology (PubMed). Pharmacological interventions targeting cognition and related clinical outcomes in vascular dementia: a systematic review and meta-analysis of randomized controlled trials.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42635820/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Pediatric emergency care (PubMed)Sep 7, 2026Research Article

A double-blind randomized trial found no reduction in vomiting or faster oral tolerance with intravenous pantoprazole versus placebo in children with acute gastroenteritis and persistent vomiting after ondansetron.

Peds EmergencyAI summaryReview source

Research ArticleResearchMedication SafetyAI summary · original source linked below

The trial randomized 100 children. Vomiting episodes and oral tolerance at 6 and 12 hours did not differ significantly, while median hospital stay was 2 days with pantoprazole and 1 day with placebo.

Key takeaways

The median participant age was 14 months, and 67% of participants were male.
Oral tolerance at 12 hours was 86% in both groups.
The longer stay associated with pantoprazole requires cautious interpretation because this was a single-center trial.

Why this matters on shift

The trial does not support empiric intravenous proton-pump inhibition for persistent vomiting in pediatric acute gastroenteritis after ondansetron.

Bedside takeaway

Clarify the indication for empiric acid suppression and keep hydration and oral-tolerance assessment central to care.

Nursing implications

Prioritize the ordered hydration and oral-tolerance plan, document ongoing emesis, and clarify the indication before administering empiric acid suppression.

Limitations & cautions

Abstract-only summary. This was a single-center study of 100 children in Tehran, and the abstract does not describe adverse events or explain why hospitalization was longer in the pantoprazole group.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Pediatric emergency care (PubMed). Effect of Intravenous Pantoprazole on Clinical Outcomes in Pediatric Acute Gastroenteritis: A Placebo-Controlled RCT.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Journal of neurosurgical anesthesiology (PubMed)Sep 4, 2026Research Article

A five-center randomized trial found similar rescue-opioid use and moderate-to-severe PACU pain with dexmedetomidine-based opioid-sparing analgesia and fentanyl-based analgesia during elective craniotomy for brain tumors.

Emergency ICUAI summaryReview source

Research ArticleResearchMedication SafetyAI summary · original source linked below

The trial randomized 500 adults. Moderate-to-severe PACU pain occurred in 145 of 242 assessed participants in the fentanyl group and 138 of 233 in the dexmedetomidine group, with no significant difference.

Key takeaways

Intraoperative rescue fentanyl use did not differ significantly between groups.
Hypotension was more common with dexmedetomidine, while postoperative shivering was less common.
Other in-hospital outcomes were similar between the two regimens.

Why this matters on shift

An opioid-sparing label did not translate into better early pain control in this trial, and the differing hypotension and shivering profiles remain relevant during perioperative handoff and recovery monitoring.

Bedside takeaway

Monitor pain, hemodynamics, sedation, and shivering in relation to the analgesic regimen and local protocol.

Nursing implications

During PACU and postoperative handoff, monitor pain, hemodynamics, sedation, and shivering according to the administered regimen and local protocol.

Limitations & cautions

Abstract-only summary. The trial involved elective tumor craniotomy at five Indian centers, both groups also received locoregional analgesia, and the abstract does not provide longer-term outcome results in detail.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Journal of neurosurgical anesthesiology (PubMed). Opioid-Sparing Versus Opioid-Based Analgesia for Craniotomy: A Multicenter Randomized Controlled Trial.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Journal of the American Medical Directors Association (PubMed)Sep 5, 2026Research Article

A prospective Dutch nursing-home cohort found clinically important differences in illness burden across respiratory viruses, with influenza and human metapneumovirus standing out.

Geriatrics Med-SurgAI summaryReview source

Research ArticleResearchInfection ControlAI summary · original source linked below

Among 3,195 residents at 15 nursing homes, 526 suspected acute respiratory-infection episodes were recorded and a virus was identified in 291. Influenza A was associated with delayed recovery, oxygen use, and threefold secondary-bacterial-pneumonia risk; hMPV was linked to fourfold more time in bed.

Key takeaways

SARS-CoV-2, influenza A, rhinovirus or enterovirus, and RSV were the most frequently identified viruses.
hMPV and RSV tended to have higher odds of moderate or severe disease.
Virus-specific patterns were associations from a cohort, not randomized comparisons.

Why this matters on shift

Frailty can amplify respiratory-infection consequences, and the causative virus may help anticipate recovery, oxygen, mobility, and secondary-infection needs.

Bedside takeaway

Trend oxygen needs, mobility, recovery, and secondary-pneumonia signs during nursing-home respiratory infections.

Nursing implications

During outbreaks or suspected infection, trend oxygen needs, mobility and time in bed, recovery, and signs of bacterial pneumonia according to facility protocols.

Limitations & cautions

Abstract-only summary. Data came from 15 Dutch nursing homes, the overall suspected-infection risk estimate was imprecise, and virus-outcome comparisons may be affected by confounding and small subgroup counts.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Journal of the American Medical Directors Association (PubMed). Clinical Impact of Acute Respiratory Virus Infections in Nursing Home Residents.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

How This Applies in Practice

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

IV pantoprazole did not improve vomiting or oral tolerance in pediatric gastroenteritis

Dexmedetomidine did not improve early pain outcomes versus fentanyl for craniotomy

Influenza and hMPV carried substantial illness burden in nursing home residents